Innovation in Ireland →
Founder and CEO, Lighter Capital
CEO and Fund Manager, Renaissance Venture Capital Fund
Professor, Michigan State University
Managing General Partner at Pappas Ventures
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
June 1, 2015 ·
June 17, 2015 ·
Ambrx is developing engineered protein drugs.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.